Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David Engelmann
E2F1 Confers Anticancer Drug Resistance by Targeting ABC Transporter Family Members and BCL-2 via the P73/DNp73-miR-205 Circuitry
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Related publications
Targeting the BCL-2 Family for Cancer Therapy
Expert Opinion on Therapeutic Targets
Molecular Medicine
Drug Discovery
Clinical Biochemistry
Pharmacology
miR-363 Confers Taxane Resistance in Ovarian Cancer by Targeting the Hippo Pathway Member, LATS2
Oncotarget
Oncology
Multimodal Targeting of the BCL-2 Family in Cancer
AACR Education book
2-Deoxyglucose-Induced Toxicity Is Regulated by BCL-2 Family Members and Is Enhanced by Antagonizing BCL-2 in Lymphoma Cell Lines
Oncogene
Cancer Research
Genetics
Molecular Biology
BCL-2 Family Members: Dual Regulators of Apoptosis and Autophagy
Autophagy
Cell Biology
Molecular Biology
BCL-2 Family Members as Prognostic Indicators in AML
Hematology
Hematology
P1.03-15 TMS Reduced Gefitinib Resistance in NSCLCs via Suppressing MAPK/Akt/Bcl-2 Pathway by Upregulation of miR-345 and miR-498
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Trans -3,5,4´-Trimethoxystilbene Reduced Gefitinib Resistance in NSCLCs via Suppressing MAPK/Akt/Bcl-2 Pathway by Upregulation of miR-345 and miR-498
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Harnessing Drug Resistance: Using ABC Transporter Proteins to Target Cancer Cells
Biochemical Pharmacology
Biochemistry
Pharmacology